888 related articles for article (PubMed ID: 22627629)
1. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
2. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
[TBL] [Abstract][Full Text] [Related]
4. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
7. CXCR-4 and COX-2 expression in basal cell carcinomas and well-differentiated squamous cell carcinomas of the skin; their relationship with tumor invasiveness and histological subtype.
Sivrikoz ON; Uyar B; Dağ F; Taşlı F; Sanal SM
Turk Patoloji Derg; 2015; 31(1):30-5. PubMed ID: 25301050
[TBL] [Abstract][Full Text] [Related]
8. HIPK2 expression in progression of cutaneous epithelial neoplasm.
Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis].
Dornelas MT; Rodrigues MF; Machado DC; Gollner AM; Ferreira AP
An Bras Dermatol; 2009; 84(5):469-75. PubMed ID: 20098848
[TBL] [Abstract][Full Text] [Related]
10. Comparison of growth hormone receptor, igf-1r and igfbp-3 between tumoral and non-tumoral areas in non-melanoma skin cancers.
Gündüz Ö; Gököz Ö; Erkın G; Akan T
Turk Patoloji Derg; 2013; 29(3):185-92. PubMed ID: 24022308
[TBL] [Abstract][Full Text] [Related]
11. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
Mihailovici MS; Teleman S; Ungureanu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin K expression in basal cell carcinoma.
Ishida M; Kojima F; Okabe H
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e128-30. PubMed ID: 22220587
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
[TBL] [Abstract][Full Text] [Related]
18. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of COX-2 in feline and canine actinic keratoses and cutaneous squamous cell carcinoma.
Bardagí M; Fondevila D; Ferrer L
J Comp Pathol; 2012 Jan; 146(1):11-7. PubMed ID: 21601872
[TBL] [Abstract][Full Text] [Related]
20. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
